Samuel Rabkin PhD

Samuel Rabkin, Ph.D., is the Thomas A. Pappas Professor in Neurosciences and Professor of Neurosurgery (Microbiology) at Harvard Medical School, Boston MA, and Virologist in Neurosurgery in the Brain Tumor Research Center at Massachusetts General Hospital, Boston. Dr. Rabkin's lab has focused on the development of oncolytic herpes simplex virus (oHSV) for cancer therapy, including the first oHSV to enter the clinical trial in the US and oHSV immunovirotherapy strategies and combinations for glioblastoma.